IMMP1LP2

Across TCGA pan-cancer cohorts, IMMP1LP2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated IMMP1LP2 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher IMMP1LP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IMMP1LP2 expression acts as an unfavorable survival marker, although some lineages such as MESO and ESCA show a favorable association.

TGCT, LGG, and MESO are the cancer types where IMMP1LP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.890	0.975	.010	54	view →
LGG	OS	Tertile	All	0.643	0.822	.001	45	view →
MESO	DFS	Tertile	All	0.618	0.326	.006	42	view →
READ	OS	Tertile	All	0.449	0.920	<.001	39	view →
UCS	OS	Tertile	II,III,IV	0.208	0.546	.023	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
LIHC	OS	Tertile	All	0.269	0.532	<.001	36	view →
LUSC	DFS	Tertile	All	0.239	0.414	.002	27	view →
ACC	DFS	Tertile	All	0.218	0.657	.021	27	view →
UVM	DFS	Tertile	III,IV	0.071	0.636	<.001	18	view →
STAD	DFS	Tertile	All	0.570	0.697	.011	13	view →
HNSC	DFS	Tertile	IV	0.558	0.704	.028	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

IMMP1LP2–TGCT (OS)

Open the TGCT breakdown →